Literature DB >> 1651957

Normative data for adrenal steroidogenesis in a healthy pediatric population: age- and sex-related changes after adrenocorticotropin stimulation.

G Lashansky1, P Saenger, K Fishman, T Gautier, D Mayes, G Berg, J Di Martino-Nardi, E Reiter.   

Abstract

The normal response to a single 0.25-mg dose of ACTH-(1-24) is not well established in infancy or childhood. We report the adrenal steroidogenic responses of 17-hydroxypregnenolone (17OH Preg), 17-hydroxyprogesterone (17OH Prog), 11-deoxycortisol, cortisol, deoxycorticosterone, dehydroepiandrosterone (DHEA), DHEA sulfate, androstenedione (A'dione), and testosterone in 102 healthy children who were divided into 5 groups: group 1 (less than 1 yr old; n = 22), group 2 (1-5 yr old; n = 22), group 3 (6-12 yr old; n = 15), group 4 (early-midpuberty; n = 21), and group 5 (late puberty; n = 22). Baseline and stimulated levels of 17OH Preg were significantly higher in group 1 infants than in group 2 children (P less than 0.01). Baseline levels of 17OH Prog increased in late puberty (P less than 0.01). Baseline and stimulated levels of DHEA rose in late puberty (group 5 vs. group 3, P less than 0.01). DHEA levels in late pubertal females were higher than those in their male counterparts (P less than 0.01). DHEA sulfate levels did not change after ACTH administration in any age group. Baseline and stimulated levels of A'dione rose significantly before the onset of puberty in female children (group 2 vs. group 3, P less than 0.01). The calculated ratio of 17OH Preg/17OH Prog in group 1 was significantly higher than that in other groups of children (P less than 0.01). The calculated, baseline DHEA/A'dione ratio was higher in group 1 than in older children (P less than 0.01). Stimulated ratios were higher in late pubertal females than in males (P less than 0.01). In both sexes baseline and stimulated ratios of 17OH Prog/deoxycorticosterone increased in puberty, such that late pubertal children had higher levels than prepubertal children (P less than 0.01). These data confirm the need for interpretation ACTH stimulation test data to be based upon age- and sex-specific norms.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1651957     DOI: 10.1210/jcem-73-3-674

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  24 in total

1.  Longitudinal stability and developmental properties of salivary cortisol levels and circadian rhythms from childhood to adolescence.

Authors:  Elizabeth A Shirtcliff; Amber L Allison; Jeffrey M Armstrong; Marcia J Slattery; Ned H Kalin; Marilyn J Essex
Journal:  Dev Psychobiol       Date:  2011-09-27       Impact factor: 3.038

2.  The clinical and biochemical spectrum of congenital adrenal hyperplasia secondary to 21-hydroxylase deficiency.

Authors:  Tony Huynh; Ivan McGown; David Cowley; Ohn Nyunt; Gary M Leong; Mark Harris; Andrew M Cotterill
Journal:  Clin Biochem Rev       Date:  2009-05

3.  Comparison of three methods for 17 alpha-hydroxyprogesterone.

Authors:  V D Castracane; T Gimpel
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

Review 4.  A New Model for Adrenarche: Inhibition of 3β-Hydroxysteroid Dehydrogenase Type 2 by Intra-Adrenal Cortisol.

Authors:  Joseph A Majzoub; Lisa Swartz Topor
Journal:  Horm Res Paediatr       Date:  2018-05-30       Impact factor: 2.852

Review 5.  Premature adrenarche.

Authors:  P Saenger; J Dimartino-Nardi
Journal:  J Endocrinol Invest       Date:  2001-10       Impact factor: 4.256

6.  Variability of cortisol assays can confound the diagnosis of adrenal insufficiency in the critically ill population.

Authors:  Jeremy Cohen; Gregory Ward; Johannes Prins; Mark Jones; Bala Venkatesh
Journal:  Intensive Care Med       Date:  2006-09-22       Impact factor: 17.440

7.  Virilizing adrenal tumour mimicking congenital adrenal hyperplasia with P450c11 (11 beta-hydroxylase) deficiency.

Authors:  E A Werder; R Voutilainen; M Zachmann
Journal:  Eur J Pediatr       Date:  1994-06       Impact factor: 3.183

8.  Assessment of adrenocortical function and autoantibodies in a baby born to a mother with autoimmune polyglandular syndrome Type 2.

Authors:  C Betterle; C Dal Pra; B Pedini; R Zanchetta; M P Albergoni; S Chen; J Furmaniak; B Rees Smith
Journal:  J Endocrinol Invest       Date:  2004 Jul-Aug       Impact factor: 4.256

9.  Rectal hydrocortisone during stress in patients with adrenal insufficiency.

Authors:  M De Vroede; R Beukering; M Spit; M Jansen
Journal:  Arch Dis Child       Date:  1998-06       Impact factor: 3.791

Review 10.  Evaluation of the hypothalamic-pituitary-adrenal axis function in childhood and adolescence.

Authors:  George P Chrousos; Tomoshige Kino; Evangelia Charmandari
Journal:  Neuroimmunomodulation       Date:  2009-06-29       Impact factor: 2.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.